Authors


Phoebe Kim, PharmD Candidate

Latest:

Introducing Tarlatamab-dlle: A New Era in Oncology Treatment

The therapy offers new hope in solid tumor treatment with fewer adverse effects.


Samantha Shi, PharmD, BCOP

Latest:

Introducing Tarlatamab-dlle: A New Era in Oncology Treatment

The therapy offers new hope in solid tumor treatment with fewer adverse effects.


Valerie Mondelli, RPh

Latest:

Embracing Digital Transformation: How Pharmacies Can Thrive in an Evolving Health Care Landscape

Pharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.



Luisa Giannangelo, MBA, RPh

Latest:

Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors

This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.


Gail Orum-Alexander, PharmD, BCGP

Latest:

Medication Therapy Management: How Pharmacists Are Personalizing Patient Care

Pharmacists have developed an expanded role in the team-based approach through medication therapy management.


Sara Luhrs, PharmD Candidate

Latest:

Clinical Overview: Certain Antihypertensive Drugs Can Lower Risk for New Onset Type 2 Diabetes

Meta-analysis of randomized controlled trials adds to growing evidence around certain antihypertensive drug classes showing promise for primary or secondary prevention of diabetes.


Bradley Winegar, PharmD

Latest:

Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial Intelligence

Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.


Aabha Daryapurkar, PharmD

Latest:

Redefining Pharmacovigilance Through Digital Innovation

AI is revolutionizing pharmacovigilance by enhancing data analysis, improving patient safety, and enabling proactive risk management in drug monitoring.


Bianka Patel, PharmD, BCOP

Latest:

A Pharmacist’s View of Emerging CML Treatment

A panelist discusses how emerging chronic myeloid leukemia treatment advancements, including the addition of asciminib as a frontline tyrosine kinase inhibitor (TKI) option and ongoing research into dual TKI therapy and optimal dosing strategies, are expanding therapeutic choices while pharmacists play a key role in educating patients and providers about evolving treatment algorithms, evaluating new literature, and helping teams manage newer agents with less clinical experience.


Alejandra C. Nogueira, PharmD Candidate

Latest:

So-Called “Ozempic Babies” Raise Questions About Unintended Effects of GLP-1 Agonists

As of now, data suggest minimal risk of drug interactions between oral contraceptives and injectable semaglutide.


Sebastian Pistritto

Latest:

Proof of Delivery is Key to Maximizing Pharmacy Reimbursement, Defending Audits and Preventing Costly Write-Offs

Five crucial steps pharmacies can take to enhance patient engagement and lower operational costs.


Johnmarc Tallegrand Jr, PharmD, RPh

Latest:

Concerns of the At-Home FluMist Emphasize Need for Patient Safety, Proper Administration

Issues around patient safety, proper administration, and monitoring need careful consideration from pharmacists and other health care providers for vaccination efforts.


Emilie Aschenbrenner, PharmD, BCOP

Latest:

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.


Dinesh Kabaleeswaran

Latest:

Claims, Lab, and EHR Data Can Make or Break a Drug Launch

Real-world data can help resolve access barriers by providing a highly detailed view into the barriers that impact specific patient populations.


Amir Saba, PharmD Candidate

Latest:

Considerations for Environmentally Conscious Pharmacy Students

Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.


Derek Burns, PharmD, MBA, BCPS, BCSCP

Latest:

Revolutionizing Treatment with Bispecific Therapies: Navigating the Challenges Ahead

By decade’s end, approval of additional bispecifics is expected for hematological malignancies, solid tumors, and non-oncology conditions such as inflammatory, autoimmune, neurodegenerative and vascular diseases, and ocular disorders and infections.


Aidan Walser, PharmD

Latest:

Improving Medication Reconciliation Accuracy in a Primary Care Practice

Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.


Paula E. Voinescu, PhD, MD

Latest:

Expert: Dual Interaction is Present Between Epilepsy and Menopause

Paula E. Voinescu, PhD, MD, emphasized the need for additional research in this area, noting it is both “surprising and upsetting.”


Garrett Meggs, PharmD

Latest:

Ashwagandha: A Case Example of the Supplement Industry

Perhaps ashwagandha may aid in stress management, athletic performance, and sleep, but this effect is far from definitive.


Adrienne Mackzum, PharmD, MS, BCPP, BCPS, APh

Latest:

Psychiatric Medication Adherence in Patients Experiencing Homelessness

Unique barriers can lead to psychiatric medication adherence rates as low as 26%.


Sam Butler, MD

Latest:

Study: Developing MIS-C Remains Rare but Significantly More Likely for Unvaccinated Children

Study shows that 98% of cases of multi-system inflammatory syndrome in children (MIS-C) were unvaccinated, suggesting that vaccination reduces the chance of a child who had COVID-19 later developing MIS-C.


Melissa Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, AAHIVP

Latest:

Managing Drug Interactions in HIV and TB Coinfection Is Complex

Best practices call for referring to resources, such as those from HHS and the University of Liverpool.


Jeanette Rich, PharmD

Latest:

Understanding the FDA Approval Process and PDUFA Dates

The FDA reviews NDAs and BLAs to approve medications for sale and marketing in the US with decisions required by the PDUFA date.


Aditi Haribhakti

Latest:

Deprescribing Helps Optimize Medication Use

Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.


Sara L. Tolliday, PharmD, RPh

Latest:

Targeting a Newly Identified Gene in the Brain May Reduce Anxiety

Anxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.




Alan M. Mancini, RPh

Latest:

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients


Tracie Acosta, CPhT

Latest:

Four Tips for Navigating Pharmacy Compliance Audits in 2022

In recent years, the auditing process has evolved into a full-blown investigation, often requiring pharmacies to submit hundreds of pages of documentation

© 2025 MJH Life Sciences

All rights reserved.